Tetraphase Pharmaceuticals Inc (TTPH) Gross Profit Margin starting from the first quarter 2020 to first quarter 2019, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Tetraphase Pharmaceuticals Inc  (NASDAQ: TTPH)


Tetraphase Pharmaceuticals Inc's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TTPH Gross Profit Margin (Mar 31 2020)
Q1 		(Dec 31 2019)
Q4 		(Sep 30 2019)
Q3 		(Jun 30 2019)
Q2 		(Mar 31 2019)
Q1
Y / Y Revenue Change 37.86 %
Seq. Revenue Change 3.85 %
Revenue In Millions $1.76
Gross Profit Margin 22.51 %
Gross Profit Margin Total Ranking # 2960
Gross Profit In Millions $0.40
Y / Y Gross Profit Change -64.38 %
Seq. Gross Profit Change 10.96 %


Commenting First Quarter 2020 Gross Profit Margin
Tetraphase Pharmaceuticals Inc Gross Profit grew by 10.96 % in Q1 sequentially to 0 millions, while Revenue increased by 3.85 %, this led to improvement in the company's Gross Profit Margin to 22.51 %, Gross Profit Margin remained below Tetraphase Pharmaceuticals Inc average.


Observing first quarter 2020 results within Major Pharmaceutical Preparations industry 159 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 2960, from total ranking in the previous quarter at 3306.
Learn about Gross Margin
TTPH's Gross Profit Margin first quarter 2020 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 160
Healthcare Sector # 446
Overall # 2888

Gross Profit Margin Statistics
High Average Low
96.96 % 62.11 % 21.07 %
(Dec 31 2018)   (Dec 31 2019)


TTPH Gross Income Trends • More of TTPH's Profitabilty Ratios • TTPH Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
TTPH's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
TTPH's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for TTPH's Competitors
Gross Profit Margin Profit Margin for Tetraphase Pharmaceuticals Inc's Suppliers
Gross Profit Margin Profit Margin for TTPH's Customers

You may also want to know
TTPH's Annual Growth Rates TTPH's Profitability Ratios TTPH's Asset Turnover Ratio TTPH's Dividend Growth
TTPH's Roe TTPH's Valuation Ratios TTPH's Financial Strength Ratios TTPH's Gross Profit Growth
TTPH's Roa TTPH's Inventory Turnover Ratio TTPH's Growth Rates TTPH's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Mar 31 2020, within Major Pharmaceutical Preparations Industry Gross Profit MarginMar 31 2020 MRQ Gross ProfitMar 31 2020 MRQ Revenue
Notable Labs Ltd   60.38 %$ 0.221  Millions$ 0.366  Millions
Ernexa Therapeutics Inc   60.32 %$ 1.444  Millions$ 2.394  Millions
Emergent Biosolutions Inc   60.05 %$ 115.600  Millions$ 192.500  Millions
Evolus Inc   59.80 %$ 6.277  Millions$ 10.496  Millions
Schrodinger Inc   59.70 %$ 15.625  Millions$ 26.174  Millions
Athenex Inc   58.30 %$ 27.363  Millions$ 46.935  Millions
Heron Therapeutics Inc   58.18 %$ 14.778  Millions$ 25.400  Millions
Rvl Pharmaceuticals Plc  57.68 %$ 28.059  Millions$ 48.649  Millions
Abbott Laboratories  57.53 %$ 4,445.000  Millions$ 7,726.000  Millions
Prestige Consumer Healthcare Inc   57.28 %$ 143.910  Millions$ 251.235  Millions
Petros Pharmaceuticals inc   56.25 %$ 1.008  Millions$ 1.792  Millions
Ani Pharmaceuticals Inc  56.19 %$ 27.970  Millions$ 49.774  Millions
Neos Therapeutics Inc   55.92 %$ 8.104  Millions$ 14.493  Millions
Cardax Inc   55.89 %$ 0.080  Millions$ 0.143  Millions
Durect Corp  55.60 %$ 1.543  Millions$ 2.775  Millions
Guardion Health Sciences Inc   55.60 %$ 0.137  Millions$ 0.246  Millions
Aimmune Therapeutics Inc   55.30 %$ 0.318  Millions$ 0.575  Millions
Igc Pharma Inc   55.17 %$ 0.016  Millions$ 0.029  Millions
Epizyme Inc.  54.65 %$ 0.740  Millions$ 1.354  Millions
Reshape Lifesciences Inc  53.93 %$ 1.504  Millions$ 2.789  Millions
Dr Reddy s Laboratories Limited  53.84 %$ 1,247.000  Millions$ 2,316.000  Millions
Cryoport inc   53.80 %$ 5.258  Millions$ 9.774  Millions
Endo International Plc  52.61 %$ 431.606  Millions$ 820.405  Millions
Collegium Pharmaceutical Inc   50.96 %$ 38.987  Millions$ 76.511  Millions
Pfenex Inc   50.15 %$ 0.342  Millions$ 0.682  Millions
Elite Pharmaceuticals Inc   49.73 %$ 2.459  Millions$ 4.945  Millions
Elanco Animal Health Incorporated  49.41 %$ 325.000  Millions$ 657.700  Millions
Cv Sciences Inc   48.46 %$ 4.008  Millions$ 8.270  Millions
Longeveron Inc   47.54 %$ 0.812  Millions$ 1.708  Millions
Teva Pharmaceutical Industries Limited  47.35 %$ 2,063.000  Millions$ 4,357.000  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.